{"id":"W4402908729","doi":"10.1016/j.ijrobp.2024.08.024","title":"Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Pneumonitis; Medicine; Adverse effect; Stage (stratigraphy); Immune system; Oncology; Lung; Internal medicine; Immunology; Immunotherapy; Pembrolizumab; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003748265,0.0001395291,0.0004678272,0.0001031407,0.0001086599,0.000346973,0.0001951575,0.0001915158,0.0008954206],"category_scores_gemma":[0.0006045563,0.00005828254,0.0002862607,0.0001402948,0.0001387415,0.0001979257,0.00008734586,0.0005380046,0.0001566207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003445527,"about_ca_system_score_gemma":0.0002918266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000455419,"about_ca_topic_score_gemma":0.001074707,"domain_scores_codex":[0.9998565,0.00005648913,0.00001271883,0.00002503217,0.00002523502,0.00002398179],"domain_scores_gemma":[0.9997815,0.00005581134,0.00006950333,0.00001795904,0.00001641428,0.00005872537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1628266,0.004680004,0.1157568,0.001159465,0.001844601,0.0008499754,0.0003298471,0.002608467,0.08387624,0.0007477847,0.003280692,0.6220396],"study_design_scores_gemma":[0.04977612,0.3498643,0.4805756,0.0004942615,0.004842535,0.00905674,0.0006276426,0.009855726,0.05785931,0.001158545,0.03580438,0.0000847787],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917926,0.006690329,0.000170667,0.0001428911,0.00002600941,0.00003433949,0.000210268,0.00001165164,0.0009212741],"genre_scores_gemma":[0.9980946,0.001159548,0.0001104172,0.0001130566,0.00001886183,0.0000166053,0.0001870487,0.000002682664,0.0002970544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008954206,"threshold_uncertainty_score":0.002995431,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02262390319140855,"score_gpt":0.3684291593653184,"score_spread":0.3458052561739098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}